Sirolimus and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Sirolimus (sirolimus), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Prednisone, and have Chronic graft versus host disease.

The phase IV clinical study analyzes which people have Dry skin when taking Sirolimus. It is created by eHealthMe based on reports of 11,812 people who have side effects when taking Sirolimus from the FDA, and is updated regularly.

What is Sirolimus?

Sirolimus has active ingredients of sirolimus. eHealthMe is studying from 11,823 Sirolimus users. Check the latest studies of Sirolimus.

What is Dry skin?

Dry skin is found to be associated with 1,991 drugs and 2,353 conditions by eHealthMe. Check the latest studies of Dry skin.

On Jul, 18, 2026

11,812 people reported to have side effects when taking Sirolimus.
Among them, 31 people (0.26%) have Dry skin.

Among these 31 people:

How long have people been on Sirolimus when they have Dry skin? *

What is the gender of people who have Dry skin when taking Sirolimus? *

female: 17.86 %
male: 82.14 %

What is the age of people who have Dry skin when taking Sirolimus? *

What are other drugs people take besides Sirolimus? *

What are other side effects people have besides Dry skin? *

Itching: 9 people, 29.03%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 8 people, 25.81%
Retinopathy Of Prematurity (retina damage in premature): 8 people, 25.81%
Blood Immunoglobulin G Decreased: 8 people, 25.81%
Skin Warm: 8 people, 25.81%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 19.35%
Visual Impairment: 6 people, 19.35%
Rashes (redness): 6 people, 19.35%
Weakness: 5 people, 16.13%
Diarrhea: 5 people, 16.13%

What are the existing conditions these people have? *

Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 6 people, 19.35%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 6.45%
Sleep Apnea Syndrome: 1 person, 3.23%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 3.23%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 3.23%
Antineutrophil Cytoplasmic Antibody Decreased: 1 person, 3.23%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.23%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 3.23%
Essential Hypertension (primary hypertension): 1 person, 3.23%
Hepatocellular Carcinoma (liver cancer): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Sirolimus and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sirolimus:

Sirolimus (11,823 reports)

Dry skin treatments and more:

Dry skin (131,310 reports)

Browse all side effects of Sirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Dry skin (1,991 drugs)

Browse all the conditions that are associated with Dry skin:

Dry skin (2,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sirolimus (the active ingredients of Sirolimus) and Sirolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.